FDW
CRDF icon

Fourth Dimension Wealth’s Cardiff Oncology CRDF Stock Holding History

Fourth Dimension Wealth’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500
Closed -$2.17K – 629
2024
Q4 		$2.17K Buy
+500
New +$1.56K ﹤0.01% 545

Other funds holding CRDF

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Fourth Dimension Wealth's CRDF Position: Q1 2025 in Review

Fourth Dimension Wealth sold out of Cardiff Oncology (CRDF) in Q1 2025, closing a stake of 500 shares — an estimated $2.17K sold.

Fourth Dimension Wealth first reported a position in CRDF in Q4 2024 and held it in 1 quarter. The position peaked at $2.17K in Q4 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2025.

  • Fourth Dimension Wealth reported no remaining Cardiff Oncology position as of Q1 2025 after selling out during the quarter.
  • Fourth Dimension Wealth sold 500 Cardiff Oncology shares in Q1 2025, an estimated $2.17K.
  • Fourth Dimension Wealth first reported a position in Cardiff Oncology in Q4 2024 and held it in 1 quarter.
  • Fourth Dimension Wealth's Cardiff Oncology position peaked at $2.17K in Q4 2024.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2025.

Based on Fourth Dimension Wealth's 13F filing for Q1 2025, filed 23 Apr 2025.